You searched for "AMM"

2004 results found

Supporting innovative eye disease research

Newmedica is supporting research into a potential next generation treatment for diabetic retinopathy, reinforcing its commitment as an eye health champion. Working in partnership with charity Sight Research UK, the project is led by Dr Michael O’Hare and his team...

Hidden eyelid laceration following blunt trauma

A paediatric case report of a hidden eyelid laceration following blunt trauma. Blunt injury to the eyelid can result in a multitude of issues, such as damage to the eyelid margin, lacrimal system and surrounding orbit [1]. These can often...

Life’s rich tapestry

Have you ever watched someone cross-stitch, or do needle-point? I recently had the joy of observing my teenage daughter create such an artwork. She separated all the threads into the various colours, and then started to follow the instructions carefully....

Medical Ophthalmological Society (MOSUK) Meeting: 22 March 2023

This year’s meeting takes place on 22 March 2023, and showcases the interdisciplinary breadth of medical ophthalmology.

CHEC announces launch of two new treatment centres

CHEC, a leading provider of community-based ophthalmology and endoscopy services in the UK, is delighted to announce the opening of two new sites in Stockport and Sheffield.

RNIB Scotland launch Glasgow drop-in sessions

Blind and partially sighted Glasgow residents will be able to get in-person support and advice at their local library, thanks to new sessions organised by a national sight loss charity.

Glaucoma UK urges people to get their eyes tested amidst rise in glaucoma cases

With the number of people living with glaucoma in the UK expected to increase by almost a third between 2020 and 2035, Glaucoma UK is urging people to get their eyes tested.

Optical Coherence Tomography: A Clinical and Technical Update

This book is a comprehensive review of the clinical and scientific aspects of optical coherence tomography (OCT). The 255 pages are divided into 11 chapters, each written by a different group of authors. Part I provides viewpoints on the clinical...

Injection frequency and anatomic outcomes following conversion to Aflibercept in neovascular AMD patients

This is a retrospective study of patients with neovascular age-related macular degeneration (AMD) treated with intravitreal Lucentis and / or Avastin who were switched to aflibercept (Eylea). This study was carried out by the Casey Eye Institute retinal clinics, between...

The willingness of patients to participate in an eye donation registry for research

This paper explores the willingness of ophthalmic patients to donate their eyes post-mortem for research purposes. A total of 300 German patients with a median age of 70 years (range 19-95) completed the standardised questionnaire; 45.3% were female and the...

Yorkshire Retina Society Winter Meeting 2024

by Madiah Mahmood, Junior Medical Education Fellow, Bradford Teaching Hospitals and Foundation Trust, UK; Ewan McCallum, Consultant Ophthalmologist, Bradford Teaching Hospitals and Foundation Trust, UK. The Yorkshire Retina Society is one of the largest regional subspecialty societies in the UK,...

Two-year GATHER2 data: anatomical gains, functional questions for avacincaptad pegol in geographic atrophy

Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) remains a leading cause of irreversible central vision loss, and complement dysregulation has long been implicated in its pathogenesis. In 2023, the US FDA approved the first two GA therapies, both...